From discovery to delivery: Fast-tracking patient access to life-saving rare disease treatments
pharmaphorum
FEBRUARY 28, 2025
From discovery to delivery: Fast-tracking patient access to life-saving rare disease treatments Mike.
pharmaphorum
FEBRUARY 28, 2025
From discovery to delivery: Fast-tracking patient access to life-saving rare disease treatments Mike.
STAT
FEBRUARY 26, 2025
The Food and Drug Administration canceled an upcoming vaccine advisory committee meeting to discuss influenza virus strains, according to committee member Paul Offit. The meeting was scheduled for March 13. Committee members received a cancellation email — which was first reported by Jeremy Faust of Inside Medicine — on Wednesday afternoon.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
FEBRUARY 24, 2025
Health agency job cuts and a newly-established MAHA commission leave many unanswered questions about potential reforms and impact on drug approvals.
Express Pharma
FEBRUARY 23, 2025
Chairman of Zydus, Pankaj Patel, emphasised the importance of people in organisational success during the launch of the School of Ultimate Leadership (SOUL) in Gujarat on Friday. Speaking at the event, formally inaugurated by Prime Minister Narendra Modi, Patel stated, People are the core to anything you do. The only mantra to succeed in any business is to take care of your people; other things will follow.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
The Pharmacist
FEBRUARY 27, 2025
Peers in the House of Lords have voted to exempt pharmacies from having to pay increased National Insurance contributions (NICs) from April. The amendment to the National Insurance Contributions (Secondary Class 1 Contributions) Bill says that specified employers, including those contracted to provide NHS pharmacy services, should only need to contribute 13.8%.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
European Pharmaceutical Review
FEBRUARY 26, 2025
A study has demonstrated a new approach to prepare tablets for intestinal drug delivery by combining two 3D printing techniques. Using both selective laser sintering (SLS) and fused deposition modelling (FDM), the technique has potential to achieve delayed and prolonged drug release, according to the findings. Key findings from the 3D printing drug delivery study [a] laser speed of 90 mm s1 was suitable for producing [3D printed tablet] cores with relatively short disintegration time and suffici
Express Pharma
FEBRUARY 26, 2025
MO Alternate Investment Advisors (MO Alts) has agreed to invest up to INR 460 crores for a majority stake in Mega Fine Pharma (Megafine).The Sanghvi Family, one of the founding-promoter groups, has also participated in this transaction, increasing their stake in the Company. Megafine, established in 1995, is an export-focused Active Pharmaceutical Ingredient (API) company based in Mumbai.
The Pharmacist
FEBRUARY 26, 2025
Guidance for the education and training of pharmacists and pharmacist independent prescribers has been updated to reflect commitments to sustainability, the General Pharmaceutical Council (GPhC) has announced. The updated guidance highlights the crucial role of pharmacists as medicines experts in working towards the more environmentally sustainable use of medicines and decreasing their associated carbon footprint […] The post GPhC updates education and training guidance to support sustaina
STAT
FEBRUARY 27, 2025
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Health care investor Kevin Tang buys “zombie” biotechs to shut them down. It’s a counterintuitive, but ingenious solution to the sector’s intractable problem covered in last week’s newsletter.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaVoice
FEBRUARY 27, 2025
Recursion CFO Ben Taylor discusses the state of AI M&A and what companies should look for as the industry moves to new data technologies and systems.
Express Pharma
FEBRUARY 27, 2025
Glenmark Pharmaceuticals Inc., USA (Glenmark) has launched Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial. The product is bioequivalent and therapeutically equivalent to Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) of BPI Labs, LLC (NDA 205029). This launch qualifies for 180 days of Competitive Generic Therapy (CGT) exclusivity under section 505(j)(5)(B)(v) of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
The Pharmacist
FEBRUARY 27, 2025
A committee of influential MPs has called for an update on the highly anticipated economic review of community pharmacy in England. The Health and Social Care Committee (HSCC) has today asked NHS England to share when it anticipates the economic analysis of the community pharmacy sector will be fully completed, and if it intends to […] The post MPs ask NHS England if, when and how it will publish economic review of pharmacy appeared first on The Pharmacist.
STAT
FEBRUARY 28, 2025
2025 bracket Welcome to STAT Madness, a bracket-style contest to find the best innovation in science and medicine. Explore groundbreaking innovations from top institutions and help crown the 2025 STAT Madness champion. Your vote determines who advances in this competition celebrating the best in biomedical research.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
FDA Law Blog: Biosimilars
FEBRUARY 23, 2025
By Steven J. Gonzalez & Allyson B. Mullen As the device industry is well aware, one of the greyest areas in device regulation (of which there are many) is determining when changes to a 510(k)-cleared device trigger the need for a new clearance. FDA requires a new 510(k) clearance when a modification to an existing 510(k)-cleared device (or other existing device subject to 510(k) requirements) could significantly affect the safety or effectiveness of the device.
PharmaVoice
FEBRUARY 28, 2025
The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.
Express Pharma
FEBRUARY 26, 2025
Dr Reddys Laboratories has recently announced that it has received the Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA) for its Active Pharmaceutical Ingredient (API) manufacturing facility (CTO-2) in Bollaram, Hyderabad. The update follows the companys earlier intimation on November 19, 2024 regarding the USFDA inspection at the facility.
STAT
FEBRUARY 28, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. It’s almost March! Which means voting for our annual STAT Madness competition starts Monday. I will see you in the brackets.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
BioPharma Dive
FEBRUARY 24, 2025
Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida Habtezion.
Pharma Times
FEBRUARY 26, 2025
Updated data from phase 2 study reveals survival benefit
Express Pharma
FEBRUARY 23, 2025
Lupin has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility in Somerset, New Jersey. The report follows an inspection conducted from 27 January to 31 January 2025. Nilesh Gupta, Managing Director of Lupin, stated, We are very pleased to have received the EIR for our Somerset facility.
STAT
FEBRUARY 27, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Can you believe the temperature in Boston hit the 50s yesterday? It’s the first false start to spring, and I’m sure that there are more cold days ahead of us. But still, it was so, so sweet.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
pharmaphorum
FEBRUARY 25, 2025
Ten out of 11 children with congenital deafness treated with a gene therapy developed by Regeneron have seen "notable" improvements in hearing
PharmaVoice
FEBRUARY 25, 2025
Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida Habtezion.
Express Pharma
FEBRUARY 23, 2025
The Appointments Committee of the Cabinet has approved the reappointment of Dr Rajeev Singh Raghuvanshi as Drugs Controller (India) at the Central Drugs Standard Control Organisation (CDSCO). The decision follows a proposal from the Department of Health and Family Welfare. According to an official notification issued by the Ministry of Personnel, Public Grievances and Pensions, Department of Personnel and Training, Dr Raghuvanshi will continue in his role on a contractual basis for one year from
STAT
FEBRUARY 25, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Everyone’s talking about egg prices, but what I’m most worried about is my apartment’s heating bill. Apparently I’m not alone.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
BioPharma Dive
FEBRUARY 25, 2025
Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s treatment, new data show.
Pharmacy Joe
FEBRUARY 23, 2025
In this episode, I’ll discuss 3 types of ICU patients and why they matter for making patient-focused risk:benefit assessments. Episode 1003: The 3 Types of ICU Patients and Why They Matter for Making Patient Focused Risk:Benefit Assessments Subscribe on iTunes , Android , or Stitcher I find that I make better patient focused risk:benefit assessments when I start off by figuring out the answer to the following question: Why is my patient in the ICU?
Express Pharma
FEBRUARY 27, 2025
Global pharma company Lupin has been included in the S&P Global Sustainability Yearbook 2025 for the second consecutive year. The recognition is based on Lupins Corporate Sustainability Assessment (CSA) score for 2024, ranking it within the top 10 per cent of its industry. The S&P Global Sustainability Yearbook selects companies based on their CSA scores, evaluating their performance in sustainability.
Let's personalize your content